Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?
- 31 March 2004
- journal article
- other
- Published by Elsevier in Lung Cancer
- Vol. 43 (3) , 369-370
- https://doi.org/10.1016/j.lungcan.2003.09.019
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and CisplatinJournal of Clinical Oncology, 2001
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy RegimensJournal of Clinical Oncology, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995